Novasep Belgium Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 400
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 3
  • Investments
  • 1

Novasep Belgium General Information

Description

Manufacturer of biopharmaceutical products based in Gosselies, Belgium. The company develops recombinant proteins, subunit and live attenuated vaccines, monoclonal antibodies and viral vectors.

Contact Information

Formerly Known As
Henogen
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • Rue Clément Ader 16
  • 6041 Gosselies
  • Belgium
+32 071 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novasep Belgium Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novasep Belgium‘s full profile, request access.

Request a free trial

Novasep Belgium Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novasep Belgium Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novasep Belgium‘s full profile, request access.

Request a free trial

Novasep Belgium Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 0000000 02-Jul-2003 000000000000000000 Biotechnology
To view Novasep Belgium’s complete acquisitions history, request access »